Colao A - Search Results

1

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study.

Colao A, Bronstein MD, Brue T, De Marinis L, Fleseriu M, Guitelman M, Raverot G, Shimon I, Fleck J, Gupta P, Pedroncelli AM, Gadelha MR. Colao A, et al. Eur J Endocrinol. 2020 Jun;182(6):583. doi: 10.1530/EJE-19-0762. Eur J Endocrinol. 2020. PMID: 32217809 Free PMC article. Clinical Trial.

2

Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly.

Colao A, Marzullo P, Lombardi G. Colao A, et al. Eur J Endocrinol. 2002 Mar;146(3):303-9. doi: 10.1530/eje.0.1460303. Eur J Endocrinol. 2002. PMID: 11888835 Clinical Trial.

3

Cardiovascular consequences of early-onset growth hormone excess.

Colao A, Spinelli L, Cuocolo A, Spiezia S, Pivonello R, di Somma C, Bonaduce D, Salvatore M, Lombardi G. Colao A, et al. J Clin Endocrinol Metab. 2002 Jul;87(7):3097-104. doi: 10.1210/jcem.87.7.8573. J Clin Endocrinol Metab. 2002. PMID: 12107207

4

Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly.

Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G. Colao A, et al. Eur J Endocrinol. 2003 Jan;148(1):31-8. doi: 10.1530/eje.0.1480031. Eur J Endocrinol. 2003. PMID: 12534355 Clinical Trial.

5

Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide.

Colao A, Marzullo P, Cuocolo A, Spinelli L, Pivonello R, Bonaduce D, Salvatore M, Lombardi G. Colao A, et al. Clin Endocrinol (Oxf). 2003 Feb;58(2):169-76. doi: 10.1046/j.1365-2265.2003.01689.x. Clin Endocrinol (Oxf). 2003. PMID: 12580932

6

Left ventricular diastolic function and cardiac performance during exercise in patients with acromegaly.

Spinelli L, Petretta M, Verderame G, Carbone G, Venetucci AA, Petretta A, Acampa W, Bonaduce D, Colao A, Cuocolo A. Spinelli L, et al. Among authors: colao a. J Clin Endocrinol Metab. 2003 Sep;88(9):4105-9. doi: 10.1210/jc.2003-030462. J Clin Endocrinol Metab. 2003. PMID: 12970271 Clinical Trial.

7

Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly.

Attanasio R, Baldelli R, Pivonello R, Grottoli S, Bocca L, Gasco V, Giusti M, Tamburrano G, Colao A, Cozzi R. Attanasio R, et al. Among authors: colao a. J Clin Endocrinol Metab. 2003 Nov;88(11):5258-65. doi: 10.1210/jc.2003-030266. J Clin Endocrinol Metab. 2003. PMID: 14602759 Clinical Trial.

8

Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.

Mattera D, Capuano G, Colao A, Pivonello R, Manguso F, Puzziello A, D'Agostino L. Mattera D, et al. Among authors: colao a. Clin Endocrinol (Oxf). 2003 Dec;59(6):699-706. doi: 10.1046/j.1365-2265.2003.01909.x. Clin Endocrinol (Oxf). 2003. PMID: 14974910

9

Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass.

Vitale G, Galderisi M, Pivonello R, Spinelli L, Ciccarelli A, de Divitiis O, Lombardi G, Colao A. Vitale G, et al. Among authors: colao a. Clin Endocrinol (Oxf). 2004 Mar;60(3):343-9. doi: 10.1111/j.1365-2265.2004.01985.x. Clin Endocrinol (Oxf). 2004. PMID: 15009000

10

Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.

Vitale G, Pivonello R, Lombardi G, Colao A. Vitale G, et al. Among authors: colao a. Treat Endocrinol. 2004;3(5):309-18. doi: 10.2165/00024677-200403050-00004. Treat Endocrinol. 2004. PMID: 15330678 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,273 results

Search Page

Filters